About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01776164

Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia

Friedreich's ataxia is characterized by progressive alterations in the function of the cerebellum accompanied by an atrophy of the spinal cord. Although the genetic defect responsible for the disease ...

Lead sponsor: University of Minnesota•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Minnesota

Collaborators

Bob Allison Ataxia Research Center
Friedreich's Ataxia Research Alliance

Age

10 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Genetic diagnosis of Friedreich's ataxia for patient volunteers with GAA repeat expansion number
•Absence of neurological conditions for control volunteers
•Control volunteers will be age-, race-, and gender-matched to the patients

Exclusion Criteria

•Claustrophobia
•Smoking
•Diabetes
•Pregnancy or lactation
•Weight over 300 lbs
•Presence of a pacemaker or any paramagnetic object in the body
•Severe scoliosis

Related studies

RECRUITINGPhase 2

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

NCT06447025 · Friedreich Ataxia

RECRUITINGPhase 1

A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

NCT06054893 · Friedreich Ataxia

Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia

NCT06692296 · Friedreich Ataxia

Active Not RecruitingPhase 1/2

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

NCT05445323 · Friedreich Ataxia, Cardiomyopathy, Secondary

COMPLETEDPhase 2/3

A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia

NCT04577352 · Friedreich Ataxia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 9, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment85

Start dateJan 2013

Last updatedMar 9, 2023

Condition

Friedreich Ataxia

Locations shown

University of Minnesota

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions